Company Filing History:
Years Active: 2003
Title: Britta Ostner: Innovator in Cytohesin-PH Peptides
Introduction
Britta Ostner is a notable inventor based in München, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that influence integrin adhesion.
Latest Patents
Ostner holds a patent for Cythohesin-PH peptides that affect the ability of integrins to adhere. This patent describes isolated cytohesin-PH peptides that can inhibit beta-2 integrins from adhering. The cytohesin-PH peptide features an amino acid sequence that comprises about a 140 amino acid domain from cytohesin-2. Additionally, assay kits that include these peptides are also provided.
Career Highlights
Britta Ostner is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical sectors. His work has focused on innovative solutions that address critical challenges in integrin-related functions.
Collaborations
Ostner has collaborated with Waldemar Kolanus, contributing to advancements in their shared field of research.
Conclusion
Britta Ostner's work in the development of cytohesin-PH peptides showcases his innovative spirit and dedication to scientific advancement. His contributions are poised to have a lasting impact on the field of biochemistry.